ES422738A1 - N-acylated substituted piperazine or homopiperazine derivatives and processes for their preparation - Google Patents

N-acylated substituted piperazine or homopiperazine derivatives and processes for their preparation

Info

Publication number
ES422738A1
ES422738A1 ES422738A ES422738A ES422738A1 ES 422738 A1 ES422738 A1 ES 422738A1 ES 422738 A ES422738 A ES 422738A ES 422738 A ES422738 A ES 422738A ES 422738 A1 ES422738 A1 ES 422738A1
Authority
ES
Spain
Prior art keywords
group
general formula
acylated
derivative
piperazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES422738A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ICHTHYOL GES CORDES HERMANNI U
Original Assignee
ICHTHYOL GES CORDES HERMANNI U
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ICHTHYOL GES CORDES HERMANNI U filed Critical ICHTHYOL GES CORDES HERMANNI U
Publication of ES422738A1 publication Critical patent/ES422738A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Abstract

Procedure for obtaining heterocyclic compounds, based on N-acylated piperazine or homopipersizine of general formula (I) **(See formula)** wherein R1, R2 and/or R3 signify hydrogen atoms, lower or higher alkyl groups, halogen atoms and/or lower alkoxy groups, or R1 and R2 signify hydrogen atoms and R3 signifies an m-trifluoromethyl group, R4 is a valence bond, a methylene group, ethylidene or an ethylene group, n represents the number 1 or 2, R5 means a lower or higher alkyl group, an allyl or propargyl group, or a group of general formula (II) **(See formula)** where R6 and/or R7 signify hydrogen atoms, lower or higher alkyl or alkoxy groups and/or halogen atoms or R6 signifies a hydrogen atom and R7 can be an m-trifluoromethyl group and R8 signifies a hydrogen atom or a lower alkyl group, as well as its addition salts with quaternary ammonium acids and derivatives, pharmaceutically or therapeutically compatible, characterized in that a piperazine or homopiperazine derivative of general formula (III) **(See formula)** it is reacted with an acid derivative capable of N-acylation of the general formula (IV) **(See formula)** where R1, R2, R3, R4, R5 and n have the meaning defined above and R9 means a halogen atom or a lower alkoxy group, or a piperazine derivative or N-acylated homopiperazine of general formula (V) **(See formula)** N-acylated at the secondary nitrogen atom, with R1, R2, R3, R4 and n having the meaning defined above, either a piperazine derivative or N-acylated homopiperazine of general formula (V) is reacted with a halogenoacetyl derivative of general formula (VI) **(See formula)** where R6, R7 and R8 have the above defined meaning and R10 means a halogen atom. (Machine-translation by Google Translate, not legally binding)
ES422738A 1973-01-29 1974-01-29 N-acylated substituted piperazine or homopiperazine derivatives and processes for their preparation Expired ES422738A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2304155A DE2304155A1 (en) 1973-01-29 1973-01-29 N-ACYLATED SUBSTITUTED PIPERAZINE AND HOMOPIPERAZINE DERIVATIVES AND THE PROCESS FOR THEIR PRODUCTION

Publications (1)

Publication Number Publication Date
ES422738A1 true ES422738A1 (en) 1976-08-01

Family

ID=5870202

Family Applications (1)

Application Number Title Priority Date Filing Date
ES422738A Expired ES422738A1 (en) 1973-01-29 1974-01-29 N-acylated substituted piperazine or homopiperazine derivatives and processes for their preparation

Country Status (7)

Country Link
JP (1) JPS505389A (en)
BE (1) BE810293A (en)
DE (1) DE2304155A1 (en)
ES (1) ES422738A1 (en)
FR (1) FR2215236B1 (en)
GB (1) GB1434323A (en)
NL (1) NL7401215A (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180574A (en) * 1978-12-26 1979-12-25 Abbott Laboratories Certain ovicidal piperazines
JPS5879986A (en) * 1981-11-06 1983-05-13 Otsuka Pharmaceut Co Ltd Aniline derivative
US4585774A (en) * 1981-05-08 1986-04-29 Otsuka Pharmaceutical Co., Ltd. Aniline derivatives and cardiotonic composition
US6207665B1 (en) 1997-06-12 2001-03-27 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
US6677343B2 (en) * 2000-02-22 2004-01-13 Cv Therapeutics, Inc. Substituted piperazine compounds
US7208497B2 (en) 2001-07-02 2007-04-24 Novo Nordisk A/S Substituted piperazines and diazepanes
EP1421071B1 (en) * 2001-07-02 2009-11-18 High Point Pharmaceuticals, LLC Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators
CA2564068A1 (en) * 2004-04-15 2005-11-17 Samaritan Pharmaceuticals, Inc. Use of (4-alkylpiperazinyl) (phenyl) methanones in the treatment of alzheimer's disease
JP2008007443A (en) * 2006-06-28 2008-01-17 Shiseido Co Ltd Cinnamic acid derivative, application of the same as ultraviolet ray absorber and ultraviolet ray absorbing composition formulated with the same, skin care preparation
WO2009031202A1 (en) * 2007-09-04 2009-03-12 Shiseido Company Ltd. Cinnamic acid derivatives and use thereof as ultraviolet absorber
CN102656151A (en) * 2009-09-04 2012-09-05 扎里卡斯药品有限公司 Substituted heterocyclic derivatives for the treatment of pain and epilepsy
US10208023B2 (en) 2013-03-01 2019-02-19 Mark G. DeGiacomo Heterocyclic inhibitors of the sodium channel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE774447A (en) * 1970-11-11 1972-02-14 Biasedra Lab NEW DERIVATIVES OF SALICYLAMIDE AND THEIR APPLICATION IN THERAPEUTICS

Also Published As

Publication number Publication date
NL7401215A (en) 1974-07-31
JPS505389A (en) 1975-01-21
FR2215236A1 (en) 1974-08-23
GB1434323A (en) 1976-05-05
BE810293A (en) 1974-05-16
DE2304155A1 (en) 1974-08-01
FR2215236B1 (en) 1977-11-04

Similar Documents

Publication Publication Date Title
GB1047935A (en) Substituted piperazines and preparation thereof
ES467288A1 (en) N-(substituted-aminoalkyl)-2-oxo-1-pyrrolidineacetamides
ES422738A1 (en) N-acylated substituted piperazine or homopiperazine derivatives and processes for their preparation
GB1120463A (en) Derivatives of 1,3-diazafluoranthene-1-oxide
ES413639A1 (en) Dopamine derivatives
ES387016A1 (en) Isoquinoline derivatives
ES405942A1 (en) 2-phenylimino-imidazolidines,their 2-aniline-2-imidazoline tautomers and salts thereof
ES331339A1 (en) Procedure for the preparation of substitute alkylpenidines. (Machine-translation by Google Translate, not legally binding)
ES391633A1 (en) 2,2,-diaryl-4-4-aryl-4-hydroxy-piperidino butyramides
ES428400A1 (en) Pheno aldehydes
ES423058A1 (en) 3-(isopropyl amino alkoxy)-2-phenyl-isoindolin-1-ones
ES390163A1 (en) Procedure for the preparation of amino-derivatives of pirazolo (3,4-b) pyridine-5-carboxylic acids. (Machine-translation by Google Translate, not legally binding)
ES417700A1 (en) Basically substituted benzene-1,3-disulfonamides and process for their manufacture
ES393934A2 (en) Derivatives of theophylline
ES419019A1 (en) Indolo-2,3-c quinolinone derivatives
ES433131A1 (en) Derivatives of 1-phenoxy-3-aminopropan-2-ol and processes for their preparation
ES422737A1 (en) Procedure for the obtaining of heterociclic compounds based on piperazine or homopiperazine. (Machine-translation by Google Translate, not legally binding)
ES301524A1 (en) Procedure for the preparation of antivirus compositions in a unit dosage form (Machine-translation by Google Translate, not legally binding)
ES435351A1 (en) 1-(3-phenylpropyl)-4-furoylpiperazine derivatives
ES442710A1 (en) A procedure for preparing new piperazine derivatives. (Machine-translation by Google Translate, not legally binding)
ES400414A1 (en) Procedure for the preparation of N-substituted piperidine derivatives and their use as stabilizers. (Machine-translation by Google Translate, not legally binding)
ES452391A1 (en) Benzisothiazoline-1,1-dioxide derivatives, compositions and methods
ES401342A1 (en) Pyridine derivatives
ES406417A1 (en) Basically substituted alkyltheophyline derivatives
ES433593A1 (en) Antibacterial cyanoquinoxaline 1,4-dioxides